Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a website transition and says “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-10-27T08:58:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-20T10:28:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, reflecting a site software update.
    Difference
    0.1%
    Check dated 2026-10-13T10:18:15.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the study record history, and the previous revision (v3.6.6) was removed from the current history view.
    Difference
    0.1%
    Check dated 2026-09-22T12:25:00.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Record history shows the page version updated from v3.6.5 to v3.6.6, indicating an internal revision of the history page. This is an administrative update and does not modify study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:28:19.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 has been added to the study's record history, indicating an update to the trial record. The previous revision v3.6.4 has been removed from the history list.
    Difference
    0.1%
    Check dated 2026-08-10T18:30:47.000Z thumbnail image

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.